Alternatives to Braeburn

Clinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.

A clinical-stage biopharmaceutical company developing psychedelic-based therapies for mental health disorders.

Aemetis is a renewable fuels and biochemicals company focused on low-carbon solutions like RNG and SAF.

Environmental services company focused on waste management and recycling solutions.

Provides comprehensive environmental services including waste management, recycling, and hazardous material disposal.

AI-guided drug discovery platform for tissue-targeted medicines.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Quantum software company enabling breakthroughs in chemistry, materials science, and life sciences.

A global leader in clinical pharmacology and bioanalytical sciences.

AI-powered platform accelerating biological research and drug discovery.

RD-Biotech develops innovative solutions for drug discovery and development using advanced biotechnology.

The first Integrated Development and Manufacturing Organization (IDMO) for cell therapies.

H1 is a healthcare data platform that connects life sciences companies with healthcare professionals.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Pioneering vision restoration therapies for severe retinal degenerations.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Developing microbiome-based therapeutics to address underlying disease biology, particularly in gastrointestinal health.

Clinical-stage biopharmaceutical company developing novel boron-based small molecule therapeutics for rare infectious diseases and oncology.

AI-powered platform for understanding disease biology and accelerating drug discovery.

A global oncology company developing and commercializing innovative cancer treatments.

Biopharmaceutical company developing best-in-class medicines for autoimmune and rare diseases, with a focus on thyroid eye disease.

Mapping cell-cell communication at scale in human tissue.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

AI platform for drug discovery and development, accelerating research with advanced computational tools.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.

AI-driven drug discovery spinoff from DeepMind using AlphaFold to discover novel medicines.

Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.

Global CRDMO providing integrated R&D and manufacturing services for the pharmaceutical and life sciences industries.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

AI-powered research assistant for scientific literature review and data extraction.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Atomwise uses AI to accelerate the discovery of novel small molecule therapeutics with its AtomNet platform.

A vertically-integrated procurement platform for the life sciences industry.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

AI platform for embryonic phenotyping that accelerates drug discovery and toxicology testing by automating analysis of embryos and organoids.

International specialty pharmaceutical company focused on central nervous system, pain management, and addiction treatments.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

A biotechnology company developing genetic therapies for rare disorders.

AI company using federated learning to solve biological complexity and accelerate drug discovery.

Pioneering 3D bioprinting company developing functional human tissue models for drug discovery and regenerative medicine

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

Designs proteins with superior properties using computational analysis, evolutionary insights, and AI.

AI-powered knowledge discovery for life sciences.

Clinical-stage biopharmaceutical company developing novel treatments for exocrine pancreatic insufficiency.

Accelerating the development of breakthrough new medicines and medical technologies.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.